Literature DB >> 11746031

Persistence of Müllerian derivatives and intestinal lymphangiectasis in two newborn brothers: confirmation of the Urioste syndrome.

C Bellini1, E Bonioli, N Josso, C Belville, M Mazzella, S Costabel, A R Sementa, C E Marino, P Tomà, R C Hennekam, G Serra.   

Abstract

We describe two newborn brothers with a pattern of malformation characterized by the persistence of Müllerian duct derivatives, intestinal lymphangiectasia, hypertrophied alveolar ridges, and early death. Postmortem examination showed the presence of a rudimentary uterus, fallopian tubes, the upper third of a vagina, a prostate of normal shape, a dilated colon, and generalized intestinal and pulmonary lymphangiectasia. The syndrome was first delineated by Urioste and co-workers [1993: Am J Med Genet 47:494-503]. These cases confirm the existence of a definite and distinct entity. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11746031     DOI: 10.1002/ajmg.1599

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

Review 1.  Primary intestinal lymphangiectasia: four case reports and a review of the literature.

Authors:  Jie Wen; Qingya Tang; Jiang Wu; Ying Wang; Wei Cai
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

Review 2.  Ocular lymphatics: state-of-the-art review.

Authors:  L Chen
Journal:  Lymphology       Date:  2009-06       Impact factor: 1.286

Review 3.  A novel CCBE1 mutation leading to a mild form of hennekam syndrome: case report and review of the literature.

Authors:  Patrick Frosk; Bernard Chodirker; Louise Simard; Wael El-Matary; Ana Hanlon-Dearman; Jeremy Schwartzentruber; Jacek Majewski; Cheryl Rockman-Greenberg
Journal:  BMC Med Genet       Date:  2015-04-30       Impact factor: 2.103

Review 4.  Congenital pulmonary lymphangiectasia.

Authors:  Carlo Bellini; Francesco Boccardo; Corradino Campisi; Eugenio Bonioli
Journal:  Orphanet J Rare Dis       Date:  2006-10-30       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.